|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
2006-8-31
|
|
pubmed:abstractText |
Since febrile neutropenic patients were recognized to constitute a heterogeneous population, several models have been developed for predicting the risk of serious medical complications. The Multinational Association for Supportive Care in Cancer score and its derived clinical prediction rules have been validated, but thus far there were no data about its use for simplifying therapy in predicted low-risk patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4129-34
|
|
pubmed:dateRevised |
2007-1-8
|
|
pubmed:meshHeading |
pubmed-meshheading:16943529-Administration, Oral,
pubmed-meshheading:16943529-Adolescent,
pubmed-meshheading:16943529-Adult,
pubmed-meshheading:16943529-Aged,
pubmed-meshheading:16943529-Aged, 80 and over,
pubmed-meshheading:16943529-Ambulatory Care,
pubmed-meshheading:16943529-Anti-Bacterial Agents,
pubmed-meshheading:16943529-Antineoplastic Agents,
pubmed-meshheading:16943529-Bacterial Infections,
pubmed-meshheading:16943529-Female,
pubmed-meshheading:16943529-Fever,
pubmed-meshheading:16943529-Humans,
pubmed-meshheading:16943529-Male,
pubmed-meshheading:16943529-Middle Aged,
pubmed-meshheading:16943529-Neutropenia,
pubmed-meshheading:16943529-Outpatients,
pubmed-meshheading:16943529-Patient Discharge,
pubmed-meshheading:16943529-Patient Readmission,
pubmed-meshheading:16943529-Predictive Value of Tests,
pubmed-meshheading:16943529-Risk Factors,
pubmed-meshheading:16943529-Severity of Illness Index
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
|
|
pubmed:affiliation |
Institut Jules Bordet, Bruxelles, Belgium.
|
|
pubmed:publicationType |
Journal Article
|
